Savara (SVRA) Tax Rate (2017 - 2018)
Savara (SVRA) posted quarterly Tax Rate of 37.37% for Q4 2018, down 13825.0% year-over-year from N/an in Q4 2017, and up 4167.52% quarter-over-quarter from 0.88% in Q3 2018.
Savara (SVRA) Tax Rate (2017 - 2018) Analysis & Trends
Savara (SVRA) has reported Tax Rate for 2 consecutive years, with 37.37% the latest figure, recorded in Q4 2018.
- In Q4 2018, Tax Rate fell 13825.0% year-over-year to 37.37%; the TTM figure through Dec 2018 stood at 5.0% (down 913.0% YoY), while the FY2019 annual figure was 31.3%, up 3156.0% from the prior year.
- Tax Rate improved to 37.37% in Q4 2018 per SVRA's latest filing, from 0.88% in the prior quarter.
- Across five years, Tax Rate topped out at 175.62% in Q4 2017 and bottomed at 0.88% in Q3 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Savara | 1.11 Bn | 1.11 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 37.37% |
| Dec 31, 2018 | 37.37% |
| Dec 31, 2018 | 37.37% |
| Sep 30, 2018 | 0.88% |
| Sep 30, 2018 | 0.88% |
| Sep 30, 2018 | 0.88% |
| Jun 30, 2018 | 2.39% |
| Jun 30, 2018 | 2.39% |
| Jun 30, 2018 | 2.39% |
| Mar 31, 2018 | 14.50% |
| Mar 31, 2018 | 14.50% |
| Mar 31, 2018 | 14.50% |
| Dec 31, 2017 | 175.63% |
| Dec 31, 2017 | 175.63% |
| Dec 31, 2017 | 175.63% |
| Sep 30, 2017 | 1.69% |
| Sep 30, 2017 | 1.69% |
| Sep 30, 2017 | 1.69% |
| Jun 30, 2017 | 3.93% |
| Jun 30, 2017 | 3.93% |